Giuseppe Sfuncia
University of Messina
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Giuseppe Sfuncia.
Anz Journal of Surgery | 2005
Antonino Versaci; Giuseppe Scuderi; Alessio Rosato; Luigi Giuseppe Angiò; Grazia Daniela Oliva; Giuseppe Sfuncia; Edoardo Saladino; Antonio Macrì
Background: The rare localizations of hydatidosis represent an interesting topic, especially with reference to epidemiological and diagnostic problems. Hydatid disease, common in Mediterranean countries, still remains endemic in some regions of Italy.
Tumori | 2009
Antonio Macrì; Antonino Versaci; Giuseppe Lupo; Giuseppe Trimarchi; Chiara Tomasello; Saverio Loddo; Giuseppe Sfuncia; Rocco Caminiti; Diana Teti; Ciro Famulari
Aim and background In breast cancer, as in almost all neoplastic diseases, the prognosis is strictly related to the invasive capacity, local and distant, that characterizes the growth of all tumors. Since the mechanisms that regulate replication of the neoplastic cells, with consequent capacity to metastasize, are not completely known, identification of new markers represents the gold standard of research in the stratification of patients with such a pathology. Osteopontin, a specific phosphoglycoprotein isolated from extracellular bone matrix and actively involved in mechanisms of bone reabsorption, appears to play a key role in osteoclastogenesis at the level of the skeleton in some pathologic situations. It has been found that patients with metastatic bone lesions from breast or prostate cancer present, with respect to subjects without repetitive bone lesions, elevated serum levels of the protein, indicating that osteopontin could play an important role in the development and progression of the neoplastic disease at the bone level. Methods and study design The authors studied 26 patients with breast cancer, evaluating as a marker also serum osteopontin levels. Results and conclusions The results, although obtained on a small number of patients, showed that osteopontin evaluation in breast cancer patients can be a particularly interesting method of research in staging of the disease as well as in the prognosis, thereby attributing a role of a biotumoral marker also in the follow-up of the therapy.
Anz Journal of Surgery | 2008
Antonino Versaci; Antonio Macr; Vincenzo Pacil; Giuseppe Sfuncia; Luigi G. Angi; Ciro Famulari
Il Giornale di chirurgia | 2009
Luigi Giuseppe Angiò; Giuseppe Sfuncia; P. Viggiani; G. Faro; A. Bonsignore; M. Licursi; M. Soliera; M. Galati; A. Putortì
International Journal of Colorectal Disease | 2004
Giuseppe Scuderi; Antonio Macrì; Giuseppe Sfuncia; F. Fedele; F. Crescenti; Antonino Versaci; Giuseppe Altavilla; Ciro Famulari
Il Giornale di chirurgia | 2003
Luigi Giuseppe Angiò; Giovanni Pirrone; Giovanna Rivoli; Maria Grazia Fracassi; Alessio Rosato; Enrico Piazzese; Vincenzo Pacilè; Giuseppe Sfuncia; Frank Fiumara
Il Giornale di chirurgia | 2007
Luigi Giuseppe Angiò; Enrico Piazzese; Vincenzo Pacilè; Giuseppe Sfuncia; A. Costantino Scirocco Fana; Frank Fiumara; A. Bonsignore; A. Biondo
Il Giornale di chirurgia | 2006
Antonino Versaci; Antonio Macrì; Giuseppe Scuderi; Antonio Certo; Giuseppe Sfuncia; Daniela G. Oliva; A. Incardona; Marisa Bonica; Luigi Familiari
Il Giornale di chirurgia | 2006
Antonino Versaci; Leonello G; Terranova M; Giorgio Ascenti; Antonio Certo; Giuseppe Sfuncia; Maddalena Grosso; Antonio Macrì
Il Giornale di chirurgia | 2005
Antonino Versaci; Leonello G; Terranova M; A. C. Scirocco; Giuseppe Sfuncia; Edoardo Saladino; Daniela G. Oliva; Antonio Macrì